Section Arrow
Quote
INM.NASDAQ
- InMed Pharmaceuticals Inc
Quotes are at least 15-min delayed:2025/07/04 07:12 EDT
Last
 2.91
-0.14 (-4.59%)
Day High 
3.025 
Prev. Close
3.05 
1-M High
5.5 
Volume 
56.88K 
Bid
2.88
Ask
2.95
Day Low
2.9 
Open
2.99 
1-M Low
2.2601 
Market Cap 
3.68M 
Currency USD 
P/E 0.02 
%Yield -- 
10-SMA 3.13 
20-SMA 2.92 
50-SMA 2.88 
52-W High 15.696 
52-W Low 1.72 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-11.65/-21.39
Enterprise Value
4.33M
Balance Sheet
Book Value Per Share
5.82
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
825.79K
Operating Revenue Per Share
3.43
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed：2025/07/04 07:12 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.